The development of advanced biopolymer-based wound dressings is critical for enhancing tissue repair and reducing inflammation. This study presents a dual-crosslinked hydrogel composed of alginate and polyvinyl alcohol (PVA), enriched with bioactive seagrass extract, synthesized through a freeze-thawing technique to improve mechanical integrity and biocompatibility for potential applications in wound healing. Structural characterization was conducted using Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), thermal analysis and field emission scanning electron microscopy (FESEM) confirmed the successful integration of the extract and the uniformity of the hydrogel matrix. Invitro cytotoxicity assessment utilizing normal human dermal fibroblast (NHDF) cell lines showed high cell viability across all concentrations, with PVAS-treated cells exhibiting over 90% viability at 100 µg/mL (p < 0.01). In vivo wound healing studies in murine models demonstrated significantly enhanced outcomes in the PVAS group compared to controls, including improved epidermal regeneration, collagen deposition, and tissue remodeling. Notably, the PVAS group achieved approximately 85% wound closure by day 21, in contrast to around 60% in untreated controls (p < 0.001). These findings underscore the potential of alginate/PVA hydrogels enriched with seagrass extract as effective, biocompatible wound dressings and support their continued development for applications in regenerative medicine.
{"title":"Enhanced wound healing through alginate/PVA hydrogels enriched with seagrass extract: an in vivo and in vitro evaluation.","authors":"Varalakshmi Sureka, Suresh Vasugi, Kudalavagothi Afeeza, Boopathy Priya Dharshini, Ponnala Anandakumar, Elangovan Dilipan","doi":"10.1080/09205063.2025.2504709","DOIUrl":"10.1080/09205063.2025.2504709","url":null,"abstract":"<p><p>The development of advanced biopolymer-based wound dressings is critical for enhancing tissue repair and reducing inflammation. This study presents a dual-crosslinked hydrogel composed of alginate and polyvinyl alcohol (PVA), enriched with bioactive seagrass extract, synthesized through a freeze-thawing technique to improve mechanical integrity and biocompatibility for potential applications in wound healing. Structural characterization was conducted using Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), thermal analysis and field emission scanning electron microscopy (FESEM) confirmed the successful integration of the extract and the uniformity of the hydrogel matrix. Invitro cytotoxicity assessment utilizing normal human dermal fibroblast (NHDF) cell lines showed high cell viability across all concentrations, with PVAS-treated cells exhibiting over 90% viability at 100 µg/mL (<i>p < 0.01</i>). <i>In vivo</i> wound healing studies in murine models demonstrated significantly enhanced outcomes in the PVAS group compared to controls, including improved epidermal regeneration, collagen deposition, and tissue remodeling. Notably, the PVAS group achieved approximately 85% wound closure by day 21, in contrast to around 60% in untreated controls (<i>p</i> < 0.001). These findings underscore the potential of alginate/PVA hydrogels enriched with seagrass extract as effective, biocompatible wound dressings and support their continued development for applications in regenerative medicine.</p>","PeriodicalId":15195,"journal":{"name":"Journal of Biomaterials Science, Polymer Edition","volume":" ","pages":"2513-2529"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144078107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-06-02DOI: 10.1080/09205063.2025.2510441
Hitesh Kumar Dewangan, Roshan Sharma, Harneet Marwah, Kamal Shah, Perwez Alam
This study focuses on the development and evaluation of solid lipid nanoparticles (SLNs) as an efficient carrier for the co-delivery of paclitaxel (PTX) and kaempferol (KMF) in breast cancer treatment. PTX, a BCS (Biopharmaceutics Classification System)-IV class drug, was combined with KMF, a flavonoid extracted and isolated from bee pollen, to enhance therapeutic efficacy. The optimal synergistic ratio of PTX and KMF was incorporated into SLNs using a hot homogenization technique, resulting in PTX-KMF-SLNs with a stable core-shell structure, narrow size distribution (166.1 ± 3.2 nm), and high encapsulation efficiency (86.15 ± 4.52%). In vitro studies demonstrated that PTX-KMF-SLNs exhibited five times greater cytotoxicity against breast cancer cells compared to the free drug combination while minimizing systemic toxicity. Preclinical evaluation further confirmed a significant reduction in tumor volume, highlighting the enhanced therapeutic potential of the nanoformulation. The antioxidant properties of KMF contributed to improved drug stability and targeted delivery, making PTX-KMF-SLNs a promising nanocarrier system for breast cancer therapy. The nanoformulation SLNs effectively reduced tumor volume in preclinical models, showing strong therapeutic potential. Future prospects include clinical translation, personalized therapy, application to other cancers, and development of targeted or stimuli-responsive delivery systems. This formulation represents a promising strategy for safe and effective breast cancer therapy.
{"title":"Nanostructured solid lipid for Paclitaxel and Kaempferol co-delivery as a novel synergistic approach for breast cancer.","authors":"Hitesh Kumar Dewangan, Roshan Sharma, Harneet Marwah, Kamal Shah, Perwez Alam","doi":"10.1080/09205063.2025.2510441","DOIUrl":"10.1080/09205063.2025.2510441","url":null,"abstract":"<p><p>This study focuses on the development and evaluation of solid lipid nanoparticles (SLNs) as an efficient carrier for the co-delivery of paclitaxel (PTX) and kaempferol (KMF) in breast cancer treatment. PTX, a BCS (Biopharmaceutics Classification System)-IV class drug, was combined with KMF, a flavonoid extracted and isolated from bee pollen, to enhance therapeutic efficacy. The optimal synergistic ratio of PTX and KMF was incorporated into SLNs using a hot homogenization technique, resulting in PTX-KMF-SLNs with a stable core-shell structure, narrow size distribution (166.1 ± 3.2 nm), and high encapsulation efficiency (86.15 ± 4.52%). <i>In vitro</i> studies demonstrated that PTX-KMF-SLNs exhibited five times greater cytotoxicity against breast cancer cells compared to the free drug combination while minimizing systemic toxicity. Preclinical evaluation further confirmed a significant reduction in tumor volume, highlighting the enhanced therapeutic potential of the nanoformulation. The antioxidant properties of KMF contributed to improved drug stability and targeted delivery, making PTX-KMF-SLNs a promising nanocarrier system for breast cancer therapy. The nanoformulation SLNs effectively reduced tumor volume in preclinical models, showing strong therapeutic potential. Future prospects include clinical translation, personalized therapy, application to other cancers, and development of targeted or stimuli-responsive delivery systems. This formulation represents a promising strategy for safe and effective breast cancer therapy.</p>","PeriodicalId":15195,"journal":{"name":"Journal of Biomaterials Science, Polymer Edition","volume":" ","pages":"2837-2858"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144208616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-06-23DOI: 10.1080/09205063.2025.2511997
Syed Sarim Imam, Wael A Mahdi, Sultan Alshehri
Piperine (PRN) is a water-insoluble alkaloidal drug reported for different biological activities. As part of this study, Kollidone VA64 (KLD) and Soluplus (SLP) were used as carriers to develop piperine solid dispersions (PRN SDs) to enhance their solubility. The stability constant of the drug-polymer composition was determined by the phase solubility study. PRN SDs were evaluated for dissolution and saturation solubility studies to select the optimized composition. SDs were evaluated for drug-polymer compatibility by Infra-red and nuclear magnetic spectroscopy. The drug crystallinity was evaluated by scanning electron microscopy and X-Ray diffraction method. Finally, a comparative cell viability assay was performed on the breast cancer cell line. The ternary system (PRN-KLD-SLP) depicted a significantly (p < 0.05) higher stability constant value than the binary system [PRN-KLD; (2.1 folds) and PRN-SLP (2.5-folds)]. An enhanced drug release (about 1.4-folds) was found from the ternary PRN SDs (F7-F9) than binary PRN SDs (F1-F6) and free PRN. The spectral analysis and molecular docking results confirm the formation of stable SDs. SEM and XRD results revealed conversion of crystalline PRN into an amorphous form. Cell viability data demonstrated a higher viability assay than the free PRN. Based on the study, we can say that the formation of ternary solid dispersion makes PRN more soluble and shows a better dissolution rate than the binary SDs.
{"title":"Enhancement of piperine solubility by solid dispersion using Kollidone VA64 and Soluplus as polymers: physicochemical characterization, molecular docking and cell viability assay.","authors":"Syed Sarim Imam, Wael A Mahdi, Sultan Alshehri","doi":"10.1080/09205063.2025.2511997","DOIUrl":"10.1080/09205063.2025.2511997","url":null,"abstract":"<p><p>Piperine (PRN) is a water-insoluble alkaloidal drug reported for different biological activities. As part of this study, Kollidone VA64 (KLD) and Soluplus (SLP) were used as carriers to develop piperine solid dispersions (PRN SDs) to enhance their solubility. The stability constant of the drug-polymer composition was determined by the phase solubility study. PRN SDs were evaluated for dissolution and saturation solubility studies to select the optimized composition. SDs were evaluated for drug-polymer compatibility by Infra-red and nuclear magnetic spectroscopy. The drug crystallinity was evaluated by scanning electron microscopy and X-Ray diffraction method. Finally, a comparative cell viability assay was performed on the breast cancer cell line. The ternary system (PRN-KLD-SLP) depicted a significantly (<i>p</i> < 0.05) higher stability constant value than the binary system [PRN-KLD; (2.1 folds) and PRN-SLP (2.5-folds)]. An enhanced drug release (about 1.4-folds) was found from the ternary PRN SDs (F7-F9) than binary PRN SDs (F1-F6) and free PRN. The spectral analysis and molecular docking results confirm the formation of stable SDs. SEM and XRD results revealed conversion of crystalline PRN into an amorphous form. Cell viability data demonstrated a higher viability assay than the free PRN. Based on the study, we can say that the formation of ternary solid dispersion makes PRN more soluble and shows a better dissolution rate than the binary SDs.</p>","PeriodicalId":15195,"journal":{"name":"Journal of Biomaterials Science, Polymer Edition","volume":" ","pages":"2908-2930"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144475367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-06-16DOI: 10.1080/09205063.2025.2515953
Megha Satpathy
This review provides an in-depth analysis of dental bone regeneration, tracing its evolution and applications. Recent advancements in dental bone regeneration have allowed the utilization of barrier membranes to direct the regeneration process, excluding undesired cell types and fostering the growth of beneficial tissues, particularly in treating periodontal and bone defects. Over the past forty years, bone regeneration has advanced significantly, effectively enhancing periodontal ligament restoration while preventing unwanted soft-tissue growth. It is widely applied in periodontal, oral, implant, and jawbone surgeries, offering benefits such as restoring functionality and aesthetics of damaged tissues. The review also explores the structure of bone, emphasizing its biphasic nature with collagen and hydroxyapatite, which are crucial for maintaining bone strength and mechanical properties. As dental diseases like periodontitis and trauma become more prevalent, bone regeneration has gained prominence. Various graft materials, synthetic biomaterials, and techniques for creating scaffold designs have been explored. Understanding these regeneration mechanisms is key to improving dental treatments, and patient outcomes, and addressing challenges in oral health care.
{"title":"A comprehensive review of dental bone regeneration.","authors":"Megha Satpathy","doi":"10.1080/09205063.2025.2515953","DOIUrl":"10.1080/09205063.2025.2515953","url":null,"abstract":"<p><p>This review provides an in-depth analysis of dental bone regeneration, tracing its evolution and applications. Recent advancements in dental bone regeneration have allowed the utilization of barrier membranes to direct the regeneration process, excluding undesired cell types and fostering the growth of beneficial tissues, particularly in treating periodontal and bone defects. Over the past forty years, bone regeneration has advanced significantly, effectively enhancing periodontal ligament restoration while preventing unwanted soft-tissue growth. It is widely applied in periodontal, oral, implant, and jawbone surgeries, offering benefits such as restoring functionality and aesthetics of damaged tissues. The review also explores the structure of bone, emphasizing its biphasic nature with collagen and hydroxyapatite, which are crucial for maintaining bone strength and mechanical properties. As dental diseases like periodontitis and trauma become more prevalent, bone regeneration has gained prominence. Various graft materials, synthetic biomaterials, and techniques for creating scaffold designs have been explored. Understanding these regeneration mechanisms is key to improving dental treatments, and patient outcomes, and addressing challenges in oral health care.</p>","PeriodicalId":15195,"journal":{"name":"Journal of Biomaterials Science, Polymer Edition","volume":" ","pages":"2999-3038"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144302121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Puerarin (Pn), a naturally occurring flavonoid, possesses numerous therapeutic qualities, while Dextran (Dn) is a naturally derived polysaccharide. Here, we examined the puerarin-dextran complex (Pn/Dn), characterization to confirming its functional groups through morphological and structural properties. Cytocompatibility assessments on HT22 cell lines along with ROS and MDA content analysis revealed higher cytocompatibility with Pn/Dn complex treatment, when compared to heat-stressed and control groups. Additionally, elevated oxidative stress levels were found to reduce after treatment with Pn/Dn complex. Flow cytometry analysis demonstrated that HT22 cells treated with puerarin, dextran, and the Pn/Dn complex exhibited preserved viability, with a reduced percentage of cells undergoing early and late apoptosis, particularly at concentrations below 20%, indicating effective prevention of cell death. Importantly, In vivo results proposed that neuronal death in various histopathological observations involves both neurons and surrounding glial cells. These findings demonstrate that the Pn/Dn complex effectively influenced in reduced hippocampal neuronal injury in mice, as confirmed by histological examination. Overall, this study highlights the protective effects of Pn/Dn complex against heat-induced neuronal injury and oxidative stress, emphasizing their potential therapeutic applications.
{"title":"Puerarin and dextran complex alleviates heat stress-induced hippocampal apoptosis and oxidative damage: therapeutic potential for hypothalamic neuronal damage in mice.","authors":"Biyue Zhang, Weiwei Li, Yutang Wu, Chunzhan Hong, Shitu Zhuo, Miao Yu, Zeming Guo, Huasong Lin, Lichao Ye, Zhenwu Zhao","doi":"10.1080/09205063.2025.2506925","DOIUrl":"10.1080/09205063.2025.2506925","url":null,"abstract":"<p><p>Puerarin (Pn), a naturally occurring flavonoid, possesses numerous therapeutic qualities, while Dextran (Dn) is a naturally derived polysaccharide. Here, we examined the puerarin-dextran complex (Pn/Dn), characterization to confirming its functional groups through morphological and structural properties. Cytocompatibility assessments on HT22 cell lines along with ROS and MDA content analysis revealed higher cytocompatibility with Pn/Dn complex treatment, when compared to heat-stressed and control groups. Additionally, elevated oxidative stress levels were found to reduce after treatment with Pn/Dn complex. Flow cytometry analysis demonstrated that HT22 cells treated with puerarin, dextran, and the Pn/Dn complex exhibited preserved viability, with a reduced percentage of cells undergoing early and late apoptosis, particularly at concentrations below 20%, indicating effective prevention of cell death. Importantly, <i>In vivo</i> results proposed that neuronal death in various histopathological observations involves both neurons and surrounding glial cells. These findings demonstrate that the Pn/Dn complex effectively influenced in reduced hippocampal neuronal injury in mice, as confirmed by histological examination. Overall, this study highlights the protective effects of Pn/Dn complex against heat-induced neuronal injury and oxidative stress, emphasizing their potential therapeutic applications.</p>","PeriodicalId":15195,"journal":{"name":"Journal of Biomaterials Science, Polymer Edition","volume":" ","pages":"2739-2757"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144698618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-06-25DOI: 10.1080/09205063.2025.2522746
Mehmet Topuz, Erkan Karatas, Damla Ruzgar, Yuksel Akinay, Tayfun Cetin
In the study, chitosan (CS)-based Ti3C2Tx MXene/Halloysite nanotube (HNT) films were successfully synthesized using the solution casting method. The prepared films were characterized morphologically and structurally. To measure the surface wettability of the films for potential biological applications, contact angles were measured in simulated body fluid. The bacterial viability and antibacterial properties on Gram-negative (E. coli) and Gram-positive (S. aureus) bacteria were evaluated by CFU counting, and statistical analyses were performed using ANOVA. The HNT particles with a size of about 30-40 nm were homogeneously anchored onto MXene layers without partial agglomerations. The presence of micropores and functional end groups in the prepared films contributes to their antibacterial effect. The incorporation of HNT into the chitosan MXene film provided a hydrophilic character by decreasing the contact angle from 82.26° to 49.47°. Antibacterial evaluation revealed that the film exhibited high inhibition for E. coli (34.63%) and S. aureus (63%) due to the synergistic effect between HNT and MXene. These findings highlight the potential of the developed film as an antibacterial material for biomedical applications.
{"title":"Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> MXene/halloysite nanotube functionalized films for antibacterial applications.","authors":"Mehmet Topuz, Erkan Karatas, Damla Ruzgar, Yuksel Akinay, Tayfun Cetin","doi":"10.1080/09205063.2025.2522746","DOIUrl":"10.1080/09205063.2025.2522746","url":null,"abstract":"<p><p>In the study, chitosan (CS)-based Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> MXene/Halloysite nanotube (HNT) films were successfully synthesized using the solution casting method. The prepared films were characterized morphologically and structurally. To measure the surface wettability of the films for potential biological applications, contact angles were measured in simulated body fluid. The bacterial viability and antibacterial properties on Gram-negative (<i>E. coli</i>) and Gram-positive (<i>S. aureus</i>) bacteria were evaluated by CFU counting, and statistical analyses were performed using ANOVA. The HNT particles with a size of about 30-40 nm were homogeneously anchored onto MXene layers without partial agglomerations. The presence of micropores and functional end groups in the prepared films contributes to their antibacterial effect. The incorporation of HNT into the chitosan MXene film provided a hydrophilic character by decreasing the contact angle from 82.26° to 49.47°. Antibacterial evaluation revealed that the film exhibited high inhibition for <i>E. coli</i> (34.63%) and <i>S. aureus</i> (63%) due to the synergistic effect between HNT and MXene. These findings highlight the potential of the developed film as an antibacterial material for biomedical applications.</p>","PeriodicalId":15195,"journal":{"name":"Journal of Biomaterials Science, Polymer Edition","volume":" ","pages":"3185-3199"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144496732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Burn wounds encompass skin injuries resulting from exposure to thermal, cryogenic, electrical, chemical, radioactive, and frictional agents. Disruption of the skin barrier and an exaggerated inflammatory response contribute to the impaired healing of these wounds. With the development of burn wound treatment technology, the importance of comfortable treatment for burn wound is becoming increasingly prominent. In this paper, we designed a multifunctional wound dressing based on silicone gel. This dressing incorporated the analgesic drug prilocaine into the polyvinyl alcohol (PVA) coating to provide pain relief. This ensures prolonged and controlled drug release, achieving effective analgesia and wound protection. We used positron emission tomography/computed tomography (PET/CT) scanning to compare pain levels in rats, and favorable results were obtained in animal experiments. The PET/CT results showed a significant decrease in pain indicators in the experimental group compared to the control group, confirming that the analgesic function of the dressing designed in this study is effective. In conclusion, our study provides a new perspective on burn wound dressings and offers a potential new approach to alleviating severe pain associated with burn wounds.
{"title":"Prilocaine-loaded silicone dressing with dual-functionality: integrated pain management and wound protection for burn care.","authors":"Yanshu Lu, Yi Peng, Jia Cheng, Zhaochen Hu, Fengbo Yang, Xiaoli Jia, Chunjing Yu, Ling Diao, Guozhong Lyu","doi":"10.1080/09205063.2025.2522751","DOIUrl":"10.1080/09205063.2025.2522751","url":null,"abstract":"<p><p>Burn wounds encompass skin injuries resulting from exposure to thermal, cryogenic, electrical, chemical, radioactive, and frictional agents. Disruption of the skin barrier and an exaggerated inflammatory response contribute to the impaired healing of these wounds. With the development of burn wound treatment technology, the importance of comfortable treatment for burn wound is becoming increasingly prominent. In this paper, we designed a multifunctional wound dressing based on silicone gel. This dressing incorporated the analgesic drug prilocaine into the polyvinyl alcohol (PVA) coating to provide pain relief. This ensures prolonged and controlled drug release, achieving effective analgesia and wound protection. We used positron emission tomography/computed tomography (PET/CT) scanning to compare pain levels in rats, and favorable results were obtained in animal experiments. The PET/CT results showed a significant decrease in pain indicators in the experimental group compared to the control group, confirming that the analgesic function of the dressing designed in this study is effective. In conclusion, our study provides a new perspective on burn wound dressings and offers a potential new approach to alleviating severe pain associated with burn wounds.</p>","PeriodicalId":15195,"journal":{"name":"Journal of Biomaterials Science, Polymer Edition","volume":" ","pages":"3200-3225"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144784301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-08-18DOI: 10.1080/09205063.2025.2519970
Xue Liu, Xin An, Bingxue Xv, Ning Zhou, Wenxin Meng, Weibo Zhang, Guomin Wu
Current alveolar ridge preservation (ARP) materials face unresolved trade-offs between mechanical stability, bioactivity, and clinical operability. To address this, we developed a fish-derived methacrylated gelatin (FGelMA) hydrogel composited with magnesium silicate (MS) microparticles combining the low immunogenicity of FGelMA with the dual osteo-angiogenic potential of MS. To characterize the physical properties of this material, the composite hydrogels (MS/FGelMA) were tested using a mechanical tester and a rheometer, and then its biocompatibility and in vitro osteogenic properties were analyzed using bone marrow mesenchymal stem cells (BMSCs) in a three-dimensional environment. In vivo model was further established to evaluate the effect of MS/FGelMA on ARP in SD rats. The results indicated that MS/FGelMA hydrogels exhibited rapid crosslinking within 20 s (365 nm UV, 10 mW/cm2), excellent shear-thinning behavior enabled precise defect adaptation, enhanced mechanical robustness, improved osteogenesis and angiogenesis capacity, especially for the optimized 1%MS/15%FGelMA formulation. 1%MS/15%FGelMA had compressive strength of 231 ± 10.149 kPa (378.69% of pure 15%FGelMA), and 2.3-4.1 folds upregulation of osteogenic markers (RUNX2/ALP/OCN) and angiogenic marker (VEGF) in rat BMSCs cultured in 3D hydrogels compared with that in pristine FGelMA hydrogel. Micro-CT analysis revealed 1%MS/15%FGelMA had socket volume preservation of 61% (vs. 46% in controls) at 3 weeks and had bone density of 75% (vs. 62% in controls) at 6 weeks. In general, this species-independent, chairside-applicable platform demonstrates superior clinical translation potential for complex ARP scenarios.
{"title":"Chairside-applicable MS/FGelMA hydrogel with enhanced osteogenesis and mechanical adaptability for alveolar ridge preservation.","authors":"Xue Liu, Xin An, Bingxue Xv, Ning Zhou, Wenxin Meng, Weibo Zhang, Guomin Wu","doi":"10.1080/09205063.2025.2519970","DOIUrl":"10.1080/09205063.2025.2519970","url":null,"abstract":"<p><p>Current alveolar ridge preservation (ARP) materials face unresolved trade-offs between mechanical stability, bioactivity, and clinical operability. To address this, we developed a fish-derived methacrylated gelatin (FGelMA) hydrogel composited with magnesium silicate (MS) microparticles combining the low immunogenicity of FGelMA with the dual osteo-angiogenic potential of MS. To characterize the physical properties of this material, the composite hydrogels (MS/FGelMA) were tested using a mechanical tester and a rheometer, and then its biocompatibility and <i>in vitro</i> osteogenic properties were analyzed using bone marrow mesenchymal stem cells (BMSCs) in a three-dimensional environment. <i>In vivo</i> model was further established to evaluate the effect of MS/FGelMA on ARP in SD rats. The results indicated that MS/FGelMA hydrogels exhibited rapid crosslinking within 20 s (365 nm UV, 10 mW/cm<sup>2</sup>), excellent shear-thinning behavior enabled precise defect adaptation, enhanced mechanical robustness, improved osteogenesis and angiogenesis capacity, especially for the optimized 1%MS/15%FGelMA formulation. 1%MS/15%FGelMA had compressive strength of 231 ± 10.149 kPa (378.69% of pure 15%FGelMA), and 2.3-4.1 folds upregulation of osteogenic markers (RUNX2/ALP/OCN) and angiogenic marker (VEGF) in rat BMSCs cultured in 3D hydrogels compared with that in pristine FGelMA hydrogel. Micro-CT analysis revealed 1%MS/15%FGelMA had socket volume preservation of 61% (vs. 46% in controls) at 3 weeks and had bone density of 75% (vs. 62% in controls) at 6 weeks. In general, this species-independent, chairside-applicable platform demonstrates superior clinical translation potential for complex ARP scenarios.</p>","PeriodicalId":15195,"journal":{"name":"Journal of Biomaterials Science, Polymer Edition","volume":" ","pages":"3125-3149"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144873325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-05-24DOI: 10.1080/09205063.2025.2505702
Bashir Ahmad, Erkay Özgör, Doga Kavaz, Ahmad Shehu
Embedding natural products into chitosan nanoparticles (CNP) is an effective way to produce a novel combination with better antimicrobial and anticancer activities. Therefore, this study aims to incorporate carob honey (CH) into CNP, determine its potential antimicrobial along with antiproliferative activities, by well diffusion and MTT cell viability assays, respectively. Successful loading of CH in CNP was confirmed after due characterization. The nanoparticles, synthesized by ionic gelation method, produced a small (101.3 ± 4.13 nm), stable (+27.27 ± 0.95 mV), and monodispersed (0.2265 ± 0.0027) CH-loaded CNP (CHCNP). The best antibacterial activity occurred in Klebsiella pneumoniae (K. pneumoniae) (23 ± 0 mm to 16 ± 1.7 mm) followed by Escherichia coli (E. coli) (18 ± 2.0 mm to 10 ± 1 mm). Meanwhile, Aspergillus niger (A. niger) and Aspergillus flavus (A. flavus) were evenly inhibited with inhibition zones in the range of 15 ± 3 mm to 7 ± 0.8 mm and 15 ± 5 mm to 9 ± 1.4 mm, respectively. CHCNP showed a remarkable cytotoxic effect on MDA-MB-231 according to concentration and time, with IC50 of 25 ± 5 to 18 ± 2.6 μg/mL within 24-72 h. These findings demonstrated the feasibility of loading CH in CNP to form a nanoformulation that could potentially serve as a target-specific therapeutic agent in the treatments of microbial infections and breast cancer. However, there is a need for further research on the safety, dosage optimization, in vivo studies and mechanisms of action of the nanoparticles.
将天然产物包埋在壳聚糖纳米颗粒(CNP)中是一种具有较好抗菌和抗癌活性的新型组合材料。因此,本研究旨在将角豆蜜(CH)掺入CNP中,分别通过well diffusion和MTT细胞活力测定其潜在的抗菌和抗增殖活性。经过适当的表征,证实了CH在CNP中的成功加载。采用离子凝胶法制备的纳米颗粒,制备出体积小(101.3±4.13 nm)、稳定性高(+27.27±0.95 mV)、单分散(0.2265±0.0027)的ch负载CNP (CHCNP)。肺炎克雷伯菌(K. pneumoniae)的抑菌活性最好(23±0 mm ~ 16±1.7 mm),其次是大肠杆菌(E. coli)(18±2.0 mm ~ 10±1 mm)。同时,对黑曲霉(A. niger)和黄曲霉(A. flavus)的抑制范围较均匀,分别为15±3 mm ~ 7±0.8 mm和15±5 mm ~ 9±1.4 mm。CHCNP对MDA-MB-231具有明显的细胞毒作用,24-72 h内IC50为25±5 ~ 18±2.6 μg/mL。这些发现证明了在CNP中装载CH以形成纳米制剂的可行性,该纳米制剂可能作为治疗微生物感染和乳腺癌的靶向治疗药物。然而,纳米颗粒的安全性、剂量优化、体内研究和作用机制等方面还需要进一步的研究。
{"title":"Synthesis of carob honey loaded chitosan nanoparticles and determination of its antimicrobial potential and cytotoxic effect on breast cancer cell line.","authors":"Bashir Ahmad, Erkay Özgör, Doga Kavaz, Ahmad Shehu","doi":"10.1080/09205063.2025.2505702","DOIUrl":"10.1080/09205063.2025.2505702","url":null,"abstract":"<p><p>Embedding natural products into chitosan nanoparticles (CNP) is an effective way to produce a novel combination with better antimicrobial and anticancer activities. Therefore, this study aims to incorporate carob honey (CH) into CNP, determine its potential antimicrobial along with antiproliferative activities, by well diffusion and MTT cell viability assays, respectively. Successful loading of CH in CNP was confirmed after due characterization. The nanoparticles, synthesized by ionic gelation method, produced a small (101.3 ± 4.13 nm), stable (+27.27 ± 0.95 mV), and monodispersed (0.2265 ± 0.0027) CH-loaded CNP (CHCNP). The best antibacterial activity occurred in <i>Klebsiella pneumoniae (K. pneumoniae) (</i>23 ± 0 mm to 16 ± 1.7 mm) followed by <i>Escherichia coli (E. coli)</i> (18 ± 2.0 mm to 10 ± 1 mm). Meanwhile, <i>Aspergillus niger (A. niger)</i> and <i>Aspergillus flavus (A. flavus)</i> were evenly inhibited with inhibition zones in the range of 15 ± 3 mm to 7 ± 0.8 mm and 15 ± 5 mm to 9 ± 1.4 mm, respectively. CHCNP showed a remarkable cytotoxic effect on MDA-MB-231 according to concentration and time, with IC<sub>50</sub> of 25 ± 5 to 18 ± 2.6 μg/mL within 24-72 h. These findings demonstrated the feasibility of loading CH in CNP to form a nanoformulation that could potentially serve as a target-specific therapeutic agent in the treatments of microbial infections and breast cancer. However, there is a need for further research on the safety, dosage optimization, <i>in vivo</i> studies and mechanisms of action of the nanoparticles.</p>","PeriodicalId":15195,"journal":{"name":"Journal of Biomaterials Science, Polymer Edition","volume":" ","pages":"2656-2676"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144136295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01Epub Date: 2025-05-24DOI: 10.1080/09205063.2025.2509031
Yehang Liu, Aixiang Ding
4D printing of alginate hydrogels has emerged as a transformative strategy in tissue engineering, enabling the fabrication of stimuli-responsive scaffolds that recapitulate the temporal and spatial complexities of native tissues. Leveraging alginate's tunable crosslinking, biocompatibility, and easy modification, recent research has demonstrated the successful design of constructs capable of programmable shape morphing in response to physiological stimuli. This review highlights recent advances in polymer design, including methacrylated, oxidized, and ligand-functionalized alginate derivatives, and cutting-edge 4D printing technologies such as extrusion-based and photopolymerization-based printing technologies. Notably, these systems have shown promising outcomes in regenerating cartilage, bone, vascular, and neural tissues. However, key challenges remain, including the standardization of shape-morphing quantification, enhancement of mechanical robustness, improvement of host tissue integration, and the replication of native tissue complexity. This review concludes with a critical evaluation of current limitations and future directions, highlighting the potential of integrating 4D alginate hydrogel systems with emerging technologies such as artificial intelligence, machine learning, organoid models, and bioelectronic interfaces to accelerate innovation and broaden their application in tissue engineering. By synthesizing recent advancements and offering insights into the implementation of 4D alginate hydrogels, this review aims to stimulate continued progress in this rapidly evolving field.
{"title":"An overview of recent advancements in 4D printing of alginate hydrogels for tissue regeneration.","authors":"Yehang Liu, Aixiang Ding","doi":"10.1080/09205063.2025.2509031","DOIUrl":"10.1080/09205063.2025.2509031","url":null,"abstract":"<p><p>4D printing of alginate hydrogels has emerged as a transformative strategy in tissue engineering, enabling the fabrication of stimuli-responsive scaffolds that recapitulate the temporal and spatial complexities of native tissues. Leveraging alginate's tunable crosslinking, biocompatibility, and easy modification, recent research has demonstrated the successful design of constructs capable of programmable shape morphing in response to physiological stimuli. This review highlights recent advances in polymer design, including methacrylated, oxidized, and ligand-functionalized alginate derivatives, and cutting-edge 4D printing technologies such as extrusion-based and photopolymerization-based printing technologies. Notably, these systems have shown promising outcomes in regenerating cartilage, bone, vascular, and neural tissues. However, key challenges remain, including the standardization of shape-morphing quantification, enhancement of mechanical robustness, improvement of host tissue integration, and the replication of native tissue complexity. This review concludes with a critical evaluation of current limitations and future directions, highlighting the potential of integrating 4D alginate hydrogel systems with emerging technologies such as artificial intelligence, machine learning, organoid models, and bioelectronic interfaces to accelerate innovation and broaden their application in tissue engineering. By synthesizing recent advancements and offering insights into the implementation of 4D alginate hydrogels, this review aims to stimulate continued progress in this rapidly evolving field.</p>","PeriodicalId":15195,"journal":{"name":"Journal of Biomaterials Science, Polymer Edition","volume":" ","pages":"2786-2819"},"PeriodicalIF":3.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144136287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}